Mercuri Biotechnologies is the R&D and manufacturing engine behind our next-gen bio-actives and clean formulations. We develop high-performance ingredients and products at the intersection of nature and measurable science—starting with bee-venom peptides and South-Asian botanicals—built for skincare, wellness, and future functional categories. From ethical sourcing and regenerative farming partnerships to GMP-aligned production in the UK/India, we design for safety, stability, and transparency: batch-level CoAs/SDS, full INCI disclosure, traceable supply chains, and compliance workflows for CPSR/UK-EU cosmetics, REACH where applicable, and clear claims substantiation. Our toolset spans formulation chemistry, in-vitro screening, irritation/sensitization testing with third-party labs, and small-to-mid scale manufacturing—so brands (and our own labels like Punarabh) can move from brief to bottle with confidence.

Going forward, we’ll expand a modular platform of bio-active libraries (venom-derived peptides, adaptogens, and clinically minded plant extracts), white-label/OEM programs for premium partners, and a data layer for batch transparency and stability analytics. We’ll pilot microbiome-friendly and low-allergen chassis, explore encapsulation for harder-to-deliver actives, and build a repeatable route to market: R&D → safety/claims → manufacture → content/compliance pack. Commercially, we’ll support three tracks: (1) Owned brands (e.g., Punarabh hero SKUs and line extensions), (2) B2B ingredients & private label for select partners, and (3) IP development around novel extractions and sustainable processing. The result: fewer, better formulas; visible performance; and a standards-first approach that scales across the UK, EU, and India.